Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(17/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(17/week)
News
United States
(590/week)
Manufacturing
(411/week)
Energy
(331/week)
Technology
(419/week)
Other Energy
(294/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Crohn's disease
Jun 15, 2020
Mymee Appoints Melinda Decker as Chief Commercial Officer
May 07, 2020
Novel Real-World Data Findings From Ongoing TARGET-IBD Study Published In DDW Proceedings
Apr 20, 2020
Theravance Biopharma Announces Peer-Reviewed Publication Highlighting TD-1473 Program in the Journal of Crohn's and Colitis
Apr 09, 2020
Crohn's & Colitis Foundation Welcomes New National Trustees
Mar 23, 2020
Prometheus Biosciences Launches Monitr(TM) COVID-19 Assistance Program (M.C.A.P.)
Feb 25, 2020
InDex Pharmaceuticals Publishes Mechanism of Action Data for Cobitolimod in Scientific Journal
Feb 25, 2020
Connect Biopharma Enhances its Intellectual Property Estate for CBP-307, a Targeted Therapy with Potential in Multiple Autoimmune Diseases, with Patent Issuances in the United States, EU, Japan and Australia
Feb 19, 2020
Protagonist Therapeutics to Present at the SVB Leerink 9th Annual Global Healthcare Conference in New York
Feb 19, 2020
New Data Show Oral Ferric Maltol (FERACCRU®) May Be a Cost-effective Alternative to Intravenous (IV) Carboxymaltose With at Least as Great Benefits in the Quality of Life of Patients With Iron Deficiency Anaemia and Inflammatory Bowel Disease
Feb 14, 2020
New Phase 3b Interim Data from STARDUST Study Show Two-Thirds of Patients with Moderately to Severely Active Crohn's Disease Achieved Clinical Remission After Two Doses of STELARA® (ustekinumab)
Feb 11, 2020
Arena Pharmaceuticals' Presence at the European Crohn's and Colitis Organisation (ECCO) Congress Further Highlights Commitment to the GI Community
Feb 07, 2020
Protagonist Therapeutics to Present Preclinical Results on PN-943 at the 15th Congress of European Crohn's and Colitis Organization (ECCO)
Jan 30, 2020
Genedata and the Crohn's & Colitis Foundation Collaborate to Improve Patient Care in Crohn's Disease
Jan 07, 2020
Protagonist Therapeutics Achieves Milestone in Janssen Biotech, Inc., Collaboration
Dec 04, 2019
Immunic, Inc. to Present Data on IMU-856, for the First Time, at the Crohn's and Colitis Foundation's IBD Innovate Conference
Nov 25, 2019
Immunic, Inc. to Participate in Investor and Scientific Conferences in December
Nov 06, 2019
Protagonist Therapeutics Announces First Patient Dosed in a Phase 2 Study of Oral IL-23 Receptor Antagonist PTG-200 (JNJ-67864238) in the Treatment of Crohn's Disease
Oct 25, 2019
Scientists to Create a "Gut Cell Atlas" With Funding from the Helmsley Charitable Trust
Oct 02, 2019
Biomica Announces Advancement to Pre-Clinical Studies in its Inflammatory Bowel Disease Program
Sep 05, 2019
Immunic, Inc.'s Interim Dosing Analysis of IMU-838 as Part of its Ongoing Phase 2 CALDOSE-1 Study in Patients with Moderate-to-Severe Ulcerative Colitis Establishes Broad, Potentially Safe and Effective Dose Range
Page 1
››
Latest News
May 14, 2024
ispace EUROPE and CDS Sign Payload Service Agreement to Transport Precise Location Measurement Technology to...
May 14, 2024
Cyprus Office Tower with Cutting Edge Design Depends on Advanced Penetron Technology for Durability
May 14, 2024
JLR and Dassault Systèmes Extend Partnership, Deploying the 3DEXPERIENCE Platform for All Vehicle Programs...
May 14, 2024
Murata’s New LCT Redefines Power Supply Noise Suppression, Reducing Component Count and Costs
May 14, 2024
President Macron Hosts Skydweller Aero CEO at Choose France 2024
May 14, 2024
Berry Global Announces Pricing of Offering of First Priority Senior Secured Notes
May 14, 2024
Owens Corning and Masonite Announce the Extension of the Expiration Time and Early Participation Deadline for...
May 14, 2024
Xcel Energy Inc. to Webcast Annual Meeting of Shareholders
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events